AIxPAP Solution | AIxMed, Inc.

Cervical Cancer Facts

Cervical cancer is one of the most preventable types of cancer, yet it remains a public health problem and a very personal journey.

4TH

Estimated most common cancer in U.S. women

~350K(1)

Estimated U.S. deaths
per year

~660K(1)

Estimated new
U.S cases

70%(2)

High-grade 10-year recurrence rate

$2.3B(3)

Estimated U.S. expenditure for thyroid cancer care

Cervical cancer rates are dropping due to proactive screening and the HPV vaccine

Additional steps can further diminish this dreadful disease

Key Features of AIxPAP
Revolutionizing Thyroid Cancer Diagnosis with AI

AIxPAP is an AI-driven tool developed by AlxMed to improve the accuracy and efficiency of cervical cancer screening through advanced Pap smear analysis. It uses machine learning to detect early signs of cancer or precancerous changes, supporting faster, more reliable diagnoses and better patient outcomes.

functionality

It uses advanced algorithms to detect and classify abnormal cells, helping pathologists identify early signs of cervical cancer with high precision.

Integration with Clinical Practice

By automating parts of the diagnostic process, AIxPAP reduces human error and increases diagnostic consistency, integrating seamlessly into lab workflows.

Benefits

AIxPAP standardizes cell classification, providing detailed reports that help pathologists make faster, more accurate diagnoses, leading to earlier detection and better patient outcomes.

Cellular Pattern Recognition

Atypical (AUC) & suspicious (SHGUC/HGUC) cells analyzed and presented in an easy to view gallery.
Easy to read graphs and calculations
Easy to read quantitative graphs, including total # of cells
WSI microscopy options available

Enhanced Diagnostic Precision

AIxURO uses advanced algorithms to assist in cancer cell detection
AIxURO combines WSI, qualitative morphology & quantitative metrics to improve accuracy in diagnostics

Automated Reporting

Easily implement digital cytology into current daily workflows
Time management
- Eliminate need to transfer glass slides
- AI-prescreening to select abnormal cells
- Rapid diagnosis for large workloads with 50-80% reduction in review time
Easy image access for storage, retrieval, sharing, and consulting

Non-Invasive Screening

The AIxMed Cytology Viewing software is intuitive and easy to navigate
Minimal training required
Enjoy digital screening options including changing magnifications, WSI screening, annotations, and bookmarks
Uses The Paris System criteria

Improved Clinical Workflow

AIxURO software is compatible with most commonly used digital scanners
Open platform accepts .tiff, .svs, jpeg files and outputs small file sizes to maximize storage space
Compatible with existing liquid-based preparation methods

Why choose AIxPAP

AIxPAP from AIxMed helps to detect suspicious and atypical cells using minimally invasive abrasive techniques that are familiar to most patients

Book demo